Skip to content
Nonprofiteer
← PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Form 990 for tax year 2022

Filed by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA.

Totals

Total revenue
$568,384,699
Total expenses
$574,376,853
Contributions and grants received
$0
Grants paid
$52,099,004
Program service revenue
$565,569,426
Investment income
$2,760,411
Other revenue
$54,862
Total assets, end of year
$286,234,000
Total liabilities, end of year
$134,567,292
Net assets or fund balances, end of year
$151,666,708
Program services expenses (Part IX)
$0
Management and general expenses
not reported
Fundraising expenses
not reported
Program service expenses (Part III)
not reported

Program services were 0.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 2a · Program service revenue: MEMBERSHIP DUES

    total $563,063,125 · related or exempt $563,063,125

  • 2b · Program service revenue: MEETINGS, SECTIONS, STUDIES

    total $2,506,301 · related or exempt $2,506,301

  • 3 · Investment income

    total $4,307,521 · excluded $4,307,521

  • 4 · Income from investment of tax-exempt bond proceeds

    total $0

  • 5 · Royalties

    total $0

  • 6c · Rental income or loss

    real property $0 · personal property $0

  • 6d · Net rental income or loss

    total $0

  • 7a · Gross sales of assets other than inventory

    securities $29,659,010 · other assets $0

  • 7b · Less cost or other basis and sales expenses

    securities $31,185,590 · other assets $20,530

  • 7c · Gain or loss

    securities -$1,526,580 · other assets -$20,530

  • 7d · Net gain or loss

    total -$1,547,110 · excluded -$1,547,110

  • 8a · Fundraising events: gross income

    $0

  • 8b · Fundraising events: direct expenses

    $0

  • 8c · Net income from fundraising events

    total $0

  • 9a · Gaming: gross income

    $0

  • 9b · Gaming: direct expenses

    $0

  • 9c · Net income from gaming

    total $0

  • 10a · Gross sales of inventory

    $0

  • 10b · Cost of goods sold

    $0

  • 10c · Net income from sales of inventory

    total $0

  • 11a · Other revenue: OTHER INCOME

    total $54,862 · excluded $54,862

  • 11e · Other revenue, total

    $54,862

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $51,858,470

  • 2 · Grants to domestic individuals

    total $0

  • 3 · Grants to foreign organizations and individuals

    total $240,534 · program services $0

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $22,477,396

  • 6 · Compensation of disqualified persons

    total $0

  • 7 · Other salaries and wages

    total $58,909,501

  • 8 · Pension plan contributions

    total $43,191,969

  • 9 · Other employee benefits

    total $7,500,368

  • 10 · Payroll taxes

    total $5,967,615

  • 11a · Fees: management

    total $0

  • 11b · Fees: legal

    total $15,477,422

  • 11c · Fees: accounting

    total $246,111

  • 11d · Fees: lobbying

    total $104,676,553

  • 11e · Fees: professional fundraising services

    total $0

  • 11f · Fees: investment management

    total $199,089

  • 11g · Fees: other

    total $117,705,304

  • 12 · Advertising and promotion

    total $52,380,919

  • 13 · Office expenses

    total $4,467,974

  • 14 · Information technology

    total $1,975,827

  • 15 · Royalties

    total $0

  • 16 · Occupancy

    total $7,481,259

  • 17 · Travel

    total $3,590,647

  • 18 · Travel or entertainment for public officials

    total $0

  • 19 · Conferences, conventions and meetings

    total $3,932,941

  • 20 · Interest

    total $0

  • 21 · Payments to affiliates

    total $0

  • 22 · Depreciation, depletion and amortization

    total $1,364,948

  • 23 · Insurance

    total $628,786

  • 24a · Other expenses: MEMBERSHIPS

    total $51,376,757

  • 24b · Other expenses: RESEARCH STUDIES

    total $17,541,980

  • 24c · Other expenses: TAXES-OTHER

    total $702,184

  • 24d · Other expenses: EQUIPMENT EXPENSE

    total $302,065

  • 24e · All other expenses

    total $180,234

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $0 · end of year $0

  • 2 · Savings and temporary cash investments

    beginning of year $170,059,927 · end of year $178,664,265

  • 3 · Pledges and grants receivable

    beginning of year $0 · end of year $0

  • 4 · Accounts receivable

    beginning of year $802,242 · end of year $1,756,147

  • 5 · Loans and receivables from officers and key people

    beginning of year $0 · end of year $0

  • 6 · Loans and receivables from disqualified persons

    beginning of year $0 · end of year $0

  • 7 · Other notes and loans receivable

    beginning of year $0 · end of year $0

  • 8 · Inventories for sale or use

    beginning of year $0 · end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $3,663,972 · end of year $4,368,510

  • 10a · Land, buildings and equipment: cost or other basis

    $14,136,484

  • 10b · Land, buildings and equipment: accumulated depreciation

    $10,629,872

  • 10c · Land, buildings and equipment, net

    beginning of year $3,500,337 · end of year $3,506,612

  • 11 · Investments: publicly traded securities

    beginning of year $96,249,326 · end of year $78,498,072

  • 12 · Investments: other securities

    beginning of year $10,477,744 · end of year $8,808,980

  • 13 · Investments: program-related

    beginning of year $0 · end of year $0

  • 14 · Intangible assets

    beginning of year $0 · end of year $0

  • 15 · Other assets

    beginning of year $124,253 · end of year $10,631,414

  • 17 · Accounts payable and accrued expenses

    beginning of year $51,277,363 · end of year $50,159,102

  • 18 · Grants payable

    beginning of year $0 · end of year $0

  • 19 · Deferred revenue

    beginning of year $74,274,051 · end of year $48,277,680

  • 20 · Tax-exempt bond liabilities

    beginning of year $0 · end of year $0

  • 21 · Escrow or custodial account liability

    beginning of year $0 · end of year $0

  • 22 · Loans and payables to officers and key people

    beginning of year $0 · end of year $0

  • 23 · Secured mortgages and notes payable

    beginning of year $0 · end of year $0

  • 24 · Unsecured notes and loans payable

    beginning of year $0 · end of year $0

  • 25 · Other liabilities

    beginning of year $42,424,661 · end of year $36,130,510

  • 27 · Net assets without donor restrictions

    beginning of year $116,451,726 · end of year $151,666,708

  • 28 · Net assets with donor restrictions

    beginning of year $450,000 · end of year $0

Mission and programs · 2022

Mission

PHRMA'S MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE THE DISCOVERY OF IMPORTANT, NEW MEDICINES FOR PATIENTS BY BIOPHARMACEUTICAL RESEARCH COMPANIES.

Activities or mission (Part I)

SEE SCHEDULE O

  • PUBLIC POLICY ADVOCACY: PHRMA'S MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE DISCOVERY OF IMPORTANT NEW MEDICINES FOR PATIENTS BY BIOPHARMACEUTICAL RESEARCH COMPANIES. PHRMA ACHIEVES THIS MISSION BY WORKING WITH, AND ON BEHALF OF, ITS MEMBER COMPANIES BEFORE GOVERNMENTAL AND REGULATORY BODIES IN THE UNITED STATES AND THROUGHOUT THE WORLD IN SUPPORT OF PRO-PATIENT, PRO-INNOVATION POLICIES. SPECIFICALLY, PHRMA ADVOCATES FOR BROAD PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICINES THROUGH A FREE MARKET, WITHOUT GOVERNMENT PRICE CONTROLS; STRONG INTELLECTUAL PROPERTY INCENTIVES; AND TRANSPARENT, EFFICIENT REGULATION AND A FREE FLOW OF INFORMATION TO PATIENTS.

  • MEMBER SERVICES: IN REPRESENTING THE COUNTRY'S LEADING PHARMACEUTICAL RESEARCH AND BIOTECHNOLOGY COMPANIES, PHRMA PROVIDES A FORUM FOR MEMBER COMPANIES TO PARTICIPATE IN DISCUSSIONS OF RELEVANT HEALTH CARE ISSUES AND TO DEVELOP CONSENSUS POSITIONS ON MATTERS OF PUBLIC POLICY ADVOCACY. MEMBER COMPANIES PARTICIPATE IN PHRMA ACTIVITIES THROUGH REPRESENTATION ON THE BOARD OF DIRECTORS, BOARD-LEVEL COMMITTEES, STAFF WORK GROUPS, SECTIONS, AND TASK FORCES. MEMBER COMPANY REPRESENTATIVES ALSO REGULARLY COMMUNICATE WITH PHRMA STAFF.

  • GENERAL EDUCATION ABOUT BIOPHARMACEUTICAL INDUSTRY: PHRMA DISSEMINATES INFORMATION ABOUT BIOPHARMACEUTICAL COMPANIES, THEIR PRODUCTS, AND THEIR BUSINESS, SCIENTIFIC AND PHILANTHROPIC ACTIVITIES THROUGH A WIDE RANGE OF CHANNELS, INCLUDING PROFILES, REPORTS, PRINCIPLES, GUIDELINES, FACT SHEETS, POLICY PAPERS AND OTHER RESOURCES. THESE EFFORTS BOLSTER PHRMA'S ABILITY TO EDUCATE AND INFORM MEMBERS OF THE GENERAL PUBLIC AS WELL AS POLICYMAKERS, THE MEDIA, PATIENTS AND OTHERS IN THE HEALTH CARE COMMUNITY ABOUT THE BIOPHARMACEUTICAL INDUSTRY AND PHRMA'S PUBLIC POLICY ACTIVITIES IN PARTICULAR.

As filed on the 2022 return.

Listed in Part VII

  • Stephen J Ubl

    PRESIDENT & CEO

    Total calculated
    $6,847,342
    From this org
    $5,432,814
    From related orgs
    $0
    Other
    $1,414,528
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $1,855,416
    Bonus
    $2,739,833
    Other
    $837,565
    Deferred
    $1,380,500
    Nontaxable benefits
    $34,028
    Filer's total
    $6,847,342

  • Lori Reilly

    COO

    Total calculated
    $3,555,531
    From this org
    $2,926,661
    From related orgs
    $0
    Other
    $628,870
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $902,379
    Bonus
    $1,984,621
    Other
    $39,661
    Deferred
    $587,459
    Nontaxable benefits
    $41,411
    Filer's total
    $3,555,531

  • James C Stansel

    GEN COUNSEL & EVP LAW, SECY

    Total calculated
    $2,056,522
    From this org
    $1,617,280
    From related orgs
    $0
    Other
    $439,242
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $732,127
    Bonus
    $878,746
    Other
    $6,407
    Deferred
    $400,989
    Nontaxable benefits
    $38,253
    Filer's total
    $2,056,522

  • Richard Moscicki MD

    CMO & EVP, Science/RG Advocacy

    Total calculated
    $1,859,710
    From this org
    $1,801,167
    From related orgs
    $0
    Other
    $58,543
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $410,212
    Bonus
    $1,385,138
    Other
    $5,817
    Deferred
    $30,500
    Nontaxable benefits
    $28,043
    Filer's total
    $1,859,710

  • Paul A Aines

    CFO & EVP OF ADMINISTRATION

    Total calculated
    $1,448,073
    From this org
    $1,397,427
    From related orgs
    $0
    Other
    $50,646
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $321,073
    Bonus
    $1,070,552
    Other
    $5,802
    Deferred
    $29,900
    Nontaxable benefits
    $20,746
    Filer's total
    $1,448,073

  • Scott Lagagna

    SVP, State Govt Advocacy

    Total calculated
    $1,404,837
    From this org
    $1,104,839
    From related orgs
    $0
    Other
    $299,998
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $525,050
    Bonus
    $576,032
    Other
    $3,757
    Deferred
    $253,275
    Nontaxable benefits
    $46,723
    Filer's total
    $1,404,837

  • Debra DeShong

    EVP, Public Affairs

    Total calculated
    $1,392,482
    From this org
    $1,332,153
    From related orgs
    $0
    Other
    $60,329
    Hours/week
    37.5

  • Jennifer Bryant

    EVP, Policy/Research

    Total calculated
    $1,376,947
    From this org
    $1,304,375
    From related orgs
    $0
    Other
    $72,572
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $611,108
    Bonus
    $677,250
    Other
    $16,017
    Deferred
    $33,550
    Nontaxable benefits
    $39,022
    Filer's total
    $1,376,947

  • Shannon C Monsif

    SVP, Alliance

    Total calculated
    $1,344,091
    From this org
    $1,065,771
    From related orgs
    $0
    Other
    $278,320
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $530,528
    Bonus
    $530,996
    Other
    $4,247
    Deferred
    $240,618
    Nontaxable benefits
    $37,702
    Filer's total
    $1,344,091

  • Robin E Palchus

    SVP, Human Resources

    Total calculated
    $1,222,697
    From this org
    $1,163,557
    From related orgs
    $0
    Other
    $59,140
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $321,999
    Bonus
    $836,452
    Other
    $5,106
    Deferred
    $30,500
    Nontaxable benefits
    $28,640
    Filer's total
    $1,222,697

  • Tracey Merchant

    CFO & EVP of Administration

    Total calculated
    $1,179,120
    From this org
    $837,155
    From related orgs
    $0
    Other
    $341,965
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $431,315
    Bonus
    $464,000
    Other
    $436,838
    Deferred
    $39,650
    Nontaxable benefits
    $20,679
    Filer's total
    $1,392,482

    Schedule J breakdown matched by us

    Base
    $442,439
    Bonus
    $340,350
    Other
    $54,366
    Deferred
    $303,000
    Nontaxable benefits
    $38,965
    Filer's total
    $1,179,120

  • Kenneth K McKay IV

    VP, State Government Advocacy

    Total calculated
    $1,118,217
    From this org
    $904,526
    From related orgs
    $0
    Other
    $213,691
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $475,394
    Bonus
    $418,095
    Other
    $11,037
    Deferred
    $174,862
    Nontaxable benefits
    $38,829
    Filer's total
    $1,118,217

  • Anne M Pritchett

    SVP, Policy/Research

    Total calculated
    $1,090,239
    From this org
    $835,101
    From related orgs
    $0
    Other
    $255,138
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $517,544
    Bonus
    $305,626
    Other
    $11,931
    Deferred
    $240,982
    Nontaxable benefits
    $14,156
    Filer's total
    $1,090,239

    Schedule J breakdown matched by us

    Base
    $546,948
    Bonus
    $273,712
    Other
    $6,404
    Deferred
    $30,500
    Nontaxable benefits
    $18,546
    Filer's total
    $876,110

  • Anne Esposito

    SVP, Federal Advocacy

    Total calculated
    $876,110
    From this org
    $827,064
    From related orgs
    $0
    Other
    $49,046
    Hours/week
    37.5

  • Bridgett Taylor

    VP, Federal Advocacy

    Total calculated
    $835,005
    From this org
    $798,699
    From related orgs
    $0
    Other
    $36,306
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $386,637
    Bonus
    $404,425
    Other
    $7,637
    Deferred
    $30,500
    Nontaxable benefits
    $5,806
    Filer's total
    $835,005

  • Renuka Iyer

    SVP, Human Resources

    Total calculated
    $194,881
    From this org
    $175,092
    From related orgs
    $0
    Other
    $19,789
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $74,792
    Bonus
    $100,000
    Other
    $300
    Deferred
    $13,200
    Nontaxable benefits
    $6,589
    Filer's total
    $194,881

  • JJ Bienaime

    Director

    Total calculated
    $0
    Hours/week
    2

  • Jean-Michel Boers

    Director

    Total calculated
    $0
    Hours/week
    2

  • Dr Albert Bourla

    Director

    Total calculated
    $0
    Hours/week
    2

  • Robert Bradway

    Director

    Total calculated
    $0
    Hours/week
    2

  • Dr Giovanni Caforio

    Director

    Total calculated
    $0
    Hours/week
    2

  • Ivan Cheung

    Director

    Total calculated
    $0
    Hours/week
    2

  • Robert Davis

    Director

    Total calculated
    $0
    Hours/week
    2

  • Sven Dethlef

    Director

    Total calculated
    $0
    Hours/week
    2

  • Deborah Dunsire

    Director

    Total calculated
    $0
    Hours/week
    2

  • Barry Greene

    Director

    Total calculated
    $0
    Hours/week
    2

  • Sebastian Guth PHD

    Director

    Total calculated
    $0
    Hours/week
    2

  • Alexander Hardy

    Director

    Total calculated
    $0
    Hours/week
    2

  • Herve Hoppenot

    Director

    Total calculated
    $0
    Hours/week
    2

  • Paul Hudson

    Director

    Total calculated
    $0
    Hours/week
    2

  • Ken Keller

    Director

    Total calculated
    $0
    Hours/week
    2

  • Doug Langa

    Director

    Total calculated
    $0
    Hours/week
    2

  • Dr Tony Loebel

    Director

    Total calculated
    $0
    Hours/week
    2

  • David Loew

    Director

    Total calculated
    $0
    Hours/week
    2

  • Vas Narasimhan

    Chairman-Elect

    Total calculated
    $0
    Hours/week
    2

  • Dan O'Day

    Treasurer

    Total calculated
    $0
    Hours/week
    2

  • Paul Perreault

    Director

    Total calculated
    $0
    Hours/week
    2

  • Richard F Pops

    Director

    Total calculated
    $0
    Hours/week
    2

  • Tarek Rabah

    Director

    Total calculated
    $0
    Hours/week
    2

  • Mark Reisenauer

    Director

    Total calculated
    $0
    Hours/week
    2

  • David Ricks

    Director

    Total calculated
    $0
    Hours/week
    2

  • Chris Round

    Director

    Total calculated
    $0
    Hours/week
    2

  • Ramona Sequeira

    Chairman

    Total calculated
    $0
    Hours/week
    2

  • Pascal Soriot

    Director

    Total calculated
    $0
    Hours/week
    2

  • Jeff Stewart

    Director

    Total calculated
    $0
    Hours/week
    2

  • Jennifer Taubert

    Director

    Total calculated
    $0
    Hours/week
    2

  • Dr JC Tellier

    Director

    Total calculated
    $0
    Hours/week
    2

  • Emma Walmsley

    Director

    Total calculated
    $0
    Hours/week
    2

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 1a · First-class or charter travel
  • 1a · Travel for companions
  • 1a · Housing allowance or residence for personal use
  • 1a · Health or social club dues or initiation fees
  • 1a · Personal services (maid, chauffeur, chef)
  • 1b · Written policy on the line-1a expenses
  • 2 · Substantiation required before reimbursing expenses
  • 3 · Compensation committee
  • 3 · Independent compensation consultant
  • 3 · Form 990 of other organizations
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement

Answered no

None.

The filer's explanations (Part III)

PART I, LINE 1A:
FIRST CLASS TRAVEL: THE PRESIDENT IS AUTHORIZED TO TRAVEL USING FIRST CLASS. TRAVEL FOR COMPANIONS: COMPANIONS OCCASIONALLY TRAVEL WITH PHRMA EXECUTIVES ON BUSINESS TRAVEL. IN SUCH CASES, COMPANION TRAVEL IS INCLUDED IN THE TAXABLE INCOME OF THE PHRMA EXECUTIVE. HOUSING ALLOWANCE: A HOUSING ALLOWANCE IS PROVIDED TO TRACEY MERCHANT, CFO & EVP, ADMINISTRATION. IT IS PAID FOR MONTHLY BY PHRMA BEGINNING IN JULY 2022, AND IS INCLUDED IN HER INCOME ON FORM W-2. HEALTH AND WELLNESS BENEFIT: ALL PHRMA EMPLOYEES ARE ELIGIBLE TO PARTICIPATE IN PHRMA'S HEALTH AND WELLNESS BENEFIT UP TO $1,250 ANNUALLY. THE VALUE OF THIS BENEFIT IS CONSIDERED TAXABLE INCOME. PERSONAL SERVICES: THE PRESIDENT IS PROVIDED WITH A DRIVER.
PART I, LINES 4A-C:
SUPPLEMENTAL PAYMENT: DEBRA DESHONG - $429,167 PHRMA SPONSORS A NON-QUALIFIED SECTION 457(F) DEFERRED COMPENSATION PLAN. AMOUNTS PAID OUT UNDER THIS PLAN ARE INCLUDED IN PART VII (WHEN PAID) AND SCHEDULE J, RESPECTIVELY (WHEN PAID, EARNED AND REPORTED IN A PRIOR YEAR). NAME: 457F (PRIOR YEAR LTIP & DEF. COMP PAID IN 2022); 457F (LTIP & DEF. COMP AWARDED IN 2022 BUT NOT PAID UNTIL FUTURE YEARS) PRIOR YEAR PAID CURRENT YEAR AWARDED STEPHEN UBL: $1,993,058 $1,350,000 LORI REILLY: $ 539,672 $ 548,815 JAMES STANSEL: $ 449,193 $ 370,489 JENNIFER BRYANT: $ 319,057 $ 0 RICHARD MOSCICKI: $ 294,504 $ 0 SCOTT LAGANGA: $ 261,707 $ 215,849 PAUL AINES: $ 226,275 $ 0 ROBIN PALCHUS: $ 163,860 $ 0 SHANNON MONSIF: $ 231,839 $ 206,418 TRACEY MERCHANT: $ 0 $ 262,500 KENNETH K. MCKAY IV: $ 236,792 $ 144,362 ANNE M. PRITCHETT: $ 0 $ 207,432

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

  • PHRMA PAC

    527 · POLITICAL · CA · controlled entity

    Directly controlled by PHRMA

  • PHRMA INDEPENDENT EXPENDITURE COMMITTEE

    527 · POLITICAL · CA · controlled entity

    Directly controlled by PHRMA

  • PHRMA COLORADO ACTION FUND

    527 · POLITICAL · CO · controlled entity

    Directly controlled by PHRMA

  • PHRMA BETTER GOVERNMENT COMMITTEE

    527 · POLITICAL · DC · controlled entity

    Directly controlled by PHRMA

  • PHRMA TN PAC

    527 · POLITICAL · TN · controlled entity

    Directly controlled by PHRMA

  • Californians Against Deceptive Rx Prop

    527 · POLITICAL · CA · controlled entity

    Directly controlled by PHRMA

  • HEALTHY NEVADA PAC

    527 · POLITICAL · NV · controlled entity

    Directly controlled by PHRMA

  • PHRMA PNW PAC

    527 · POLITICAL · ID · controlled entity

    Directly controlled by PHRMA

Provenance

Return type
form_990
Tax year
2022
Filed
10 November 2023
IRS schema version
2022v5.0
Source object
202303189349316445

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.